Synovitis Clinical Trials

Find Synovitis Clinical Trials Near You

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pigmented villonodular synovitis (PVNS) is a rare joint disease caused by the proliferation of synovial tissue, leading to significant pain and joint destruction. It typically begins between the ages of 30 and 50 and significantly affects patients' functionality. The proliferation is due to somatic mutations in some fibroblastic cells within the tissue, which triggers a massive recruitment of inflammatory cells. The condition is considered a benign tumor of the synovial membrane with a major inflammatory component. Diagnosing PVNS requires synovial tissue analysis, obtained either through surgical excision or guided needle biopsy. This biopsy technique, done as an outpatient procedure, is well tolerated and helps confirm the diagnosis before treatment. Our goal is to better understand this disease and determine if the analysis of synovial tissue could serve as a useful biomarker for patient management in the context of personalized medicine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient \>18 years

• Diagnosis of localized or diffuse villonodular synovitis

• Referred for therapeutic management

• Affiliated with or benefiting from a social security scheme

Locations
Other Locations
France
Hospices Civils de Lyon
NOT_YET_RECRUITING
Lyon
CHU de Nantes
RECRUITING
Nantes
Hôpital Cochin APHP
NOT_YET_RECRUITING
Paris
Contact Information
Primary
Benoit Le Goff, PU-PH
benoit.legoff@chu-nantes.fr
02 40 08 48 25
Time Frame
Start Date: 2026-09
Estimated Completion Date: 2030-09
Participants
Target number of participants: 30
Treatments
Experimental: Synovial sampling
Synovial sampling on first visit
Sponsors
Leads: Nantes University Hospital

This content was sourced from clinicaltrials.gov